ADALX - Overview: Adalimumab Quantitative with Reflex to Antibody, Serum
Therapeutic drug monitoring of adalimumab concentration and antibody levels, if appropriate
CH8BI - Overview: Chromogenic Factor VIII Inhibitor Bethesda Profile Interpretation
Interpretation of CHF8P / Chromogenic Factor VIII Inhibitor Bethesda Profile, Plasma Detecting the presence and titer of a specific factor inhibitor directed against coagulation factor VIII This test is not useful for detecting the...
CHIKI - Overview: Chikungunya Interpretation
Interpretation of testing that aids in the diagnosis of recent infection with Chikungunya virus in patients with recent travel to endemic areas and a compatible clinical syndrome
2INHT - Overview: Factor II Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to factor II testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are not specific...
11INT - Overview: Factor XI Inhibitor Profile, Technical Interpretation
Technical interpretation of inhibitor to coagulation factor XI testing This test is not useful for the detection of a lupus-like circulating anticoagulant inhibitor, a nonspecific circulating anticoagulant, or other inhibitors that are...
Increased levels of neopterin are found during impaired renal function and viral infection in transplant patients. Elevated levels are also indicators for conditions related to impaired cellular immunity.
EEEVI - Overview: Red Blood Cell (RBC) Enzyme Interpretation
Interpretation of results for the red blood cell enzyme evaluation Identifying defects of red cell enzyme metabolism Evaluating patients with Coombs-negative hemolytic anemia
HBEL0 - Overview: Hemoglobin Electrophoresis Summary Interpretation
Incorporating and summarizing results into an overall evaluation for the HBEL1 / Hemoglobin Electrophoresis Evaluation, Blood
Detecting lead exposure using hair specimens
SP7CS - Overview: Septin-7 Antibody, Cell-Binding Assay, Serum
Detecting septin-7 IgG by cell-binding assay using serum specimens
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....